v3.26.3
Fair Value of Financial Instruments - Other Equity Investments - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Fair Value, Financial Instruments Measured on a Non-Recurring Basis [Line Items]          
Revenue $ 5,152,336 $ 3,966,948 $ 13,354,691 $ 10,359,371  
Related Party          
Fair Value, Financial Instruments Measured on a Non-Recurring Basis [Line Items]          
Revenue 18,300   18,300    
Subcontracting Arrangements | Related Party          
Fair Value, Financial Instruments Measured on a Non-Recurring Basis [Line Items]          
Operating costs and expenses 600 $ 900 1,500 2,900  
Accounts payable 300   300   $ 300
Other Equity Method Investments and Subcontracting Arrangements | Related Party          
Fair Value, Financial Instruments Measured on a Non-Recurring Basis [Line Items]          
Accounts receivable, after allowance for credit loss $ 2,000   2,000   $ 4,000
Other Equity Method Investments          
Fair Value, Financial Instruments Measured on a Non-Recurring Basis [Line Items]          
Equity contributions     1,600 0  
Equity method investments, distributions of earnings received, operating cash flows     $ 15,100 $ 500